Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 1999

View Archived Issues

Study results presented for ViroPharma's antiviral agent pleconaril

Angiotech presents positive results from phase I/II MS study

Exisulind leads to lower PSA levels according to interim phase II/III data

Licensing opportunity from Stanford University: treatment of autoimmune disorders

Ligand confirms that ECOG has initiated multicenter phase II study of Ontak for NHL

Gliatech files IDE for ADCON-A antiadhesion barrier

PathoGenesis launches TOBI in second market

Company Profile: Onconova Therapeutics

Inspire presents positive results for dry eye disease therapeutic

Antibody-gold cluster conjugates with broad potential application available for licensing

Duramed's conjugated estrogens now available in U.S.

Novo Nordisk presents new insulin delivery system

New selective 5-HT1B receptor antagonists disclosed by Astra (AstraZeneca)

Magainin: Annual Report 1998

Triangle, Glaxo Wellcome and Emory University resolve emtricitabine dispute

Carbapenems from Merck particularly active against methicillin-resistant Gram-positive pathogens

P&G presents new antimicrobial agents with broad spectrum, including resistant bacteria

CETP inhibitors in the Bayer pipeline

Thrombin inhibitors developed by Merck scientists

Second COX-2 inhibitor reaches the market

Cartilage-derived angiogenesis inhibitor is potentially useful in treating proliferative retinopathy

New benzazepine compound selectively inhibits vitronectin receptors

Spanish team develops microsphere delivery system for improved intravitreal use of corticosteroids

Solvay expands cardiovascular product portfolio

European Union approval obtained for Schering-Plough's combination HCV therapy

CoCensys sells holdings in Cytovia

Sunrise Technologies' hyperopia treatment system scheduled for FDA advisory panel review

Enbrel warning related to infections issued by FDA and Immunex

Oral creatine is neuroprotective in transgenic mouse model of ALS

Brain COX-2 expression and arteriolar vasodilatation in response to inflammatory stimuli

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...